SPATA31A7
gene geneOn this page
Summary
SPATA31A7 (SPATA31 subfamily A member 7, HGNC:32007) is a protein-coding gene on chromosome 9q12, encoding Spermatogenesis-associated protein 31A7 (Q8IWB4). May play a role in spermatogenesis. It is a selective cancer dependency (DepMap: 18.2% of cell lines).
Predicted to be involved in cell differentiation and spermatogenesis. Predicted to be located in membrane.
Source: NCBI Gene 26165 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 150 total
- Cancer dependency (DepMap): dependent in 18.2% of screened cell lines
- MANE Select transcript:
NM_015667
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:32007 |
| Approved symbol | SPATA31A7 |
| Name | SPATA31 subfamily A member 7 |
| Location | 9q12 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000276040 |
| Ensembl biotype | protein_coding |
| OMIM | 616584 |
| Entrez | 26165 |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 8 protein_coding_CDS_not_defined, 1 protein_coding
ENST00000376458, ENST00000611017, ENST00000614013, ENST00000618860, ENST00000619140, ENST00000619167, ENST00000621711, ENST00000622751, ENST00000622899
RefSeq mRNA: 1 — MANE Select: NM_015667
NM_015667
CCDS: CCDS75838
Canonical transcript exons
ENST00000619167 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003713001 | 61192395 | 61196280 |
| ENSE00003721714 | 61191453 | 61191510 |
| ENSE00003754137 | 61192079 | 61192139 |
| ENSE00003978169 | 61190036 | 61190253 |
Expression profiles
Bgee: expression breadth broad, 74 present calls, max score 79.19.
Top tissues by expression
100 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.19 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 76.14 | gold quality |
| right testis | UBERON:0004534 | 70.97 | gold quality |
| testis | UBERON:0000473 | 70.02 | gold quality |
| left testis | UBERON:0004533 | 69.74 | gold quality |
| sural nerve | UBERON:0015488 | 60.39 | silver quality |
| stromal cell of endometrium | CL:0002255 | 42.75 | silver quality |
| bone marrow cell | CL:0002092 | 41.81 | gold quality |
| ectocervix | UBERON:0012249 | 41.48 | gold quality |
| bone marrow | UBERON:0002371 | 41.03 | silver quality |
| lower esophagus mucosa | UBERON:0035834 | 40.90 | silver quality |
| monocyte | CL:0000576 | 39.32 | gold quality |
| leukocyte | CL:0000738 | 38.80 | gold quality |
| primary visual cortex | UBERON:0002436 | 38.00 | silver quality |
| ganglionic eminence | UBERON:0004023 | 37.81 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 37.13 | gold quality |
| apex of heart | UBERON:0002098 | 36.92 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 36.91 | gold quality |
| uterine cervix | UBERON:0000002 | 36.50 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 36.25 | gold quality |
| granulocyte | CL:0000094 | 36.05 | gold quality |
| right uterine tube | UBERON:0001302 | 34.94 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 34.83 | gold quality |
| mucosa of stomach | UBERON:0001199 | 34.60 | gold quality |
| duodenum | UBERON:0002114 | 34.55 | gold quality |
| blood | UBERON:0000178 | 34.19 | gold quality |
| urinary bladder | UBERON:0001255 | 34.08 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.31 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
23 targeting SPATA31A7, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-4747-5P | 100.00 | 67.90 | 2681 |
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548D-3P | 99.87 | 70.67 | 4362 |
| HSA-MIR-548BB-3P | 99.86 | 70.58 | 4354 |
| HSA-MIR-548AC | 99.84 | 70.77 | 4351 |
| HSA-MIR-548H-3P | 99.84 | 70.80 | 4349 |
| HSA-MIR-548Z | 99.84 | 70.80 | 4349 |
| HSA-MIR-6505-5P | 99.73 | 69.25 | 1595 |
| HSA-MIR-6833-5P | 99.50 | 68.93 | 1161 |
| HSA-MIR-519A-2-5P | 98.78 | 71.74 | 1401 |
| HSA-MIR-520B-5P | 98.78 | 71.74 | 1401 |
| HSA-MIR-4752 | 98.71 | 68.04 | 833 |
| HSA-MIR-4684-5P | 98.29 | 67.99 | 1650 |
| HSA-MIR-6810-5P | 98.29 | 66.21 | 975 |
| HSA-MIR-7113-5P | 97.88 | 67.33 | 1735 |
| HSA-MIR-376C-3P | 97.63 | 68.88 | 1263 |
| HSA-MIR-3190-3P | 97.61 | 66.95 | 1406 |
| HSA-MIR-5586-3P | 95.51 | 67.00 | 805 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 18.2% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 2)
- Results suggest that AEP1 is an evolutionary-conserved acrosome-specific gene and likely functions in acrosome-cap formation [AEP1]. (PMID:16924657)
- VAD1.3 interacts with beta-actin and syntaxin 1 in vitro. (PMID:20850414)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Spata31 | ENSMUSG00000056223 |
| rattus_norvegicus | Spata31 | ENSRNOG00000018202 |
Paralogs (13): SPATA31C2 (ENSG00000177910), SPATA31E1 (ENSG00000177992), SPATA31A6 (ENSG00000185775), SPATA31D3 (ENSG00000186788), SPATA31F3 (ENSG00000187791), SPATA31D4 (ENSG00000189357), SPATA31A1 (ENSG00000204849), SPATA31F1 (ENSG00000205108), SPATA31D1 (ENSG00000214929), SPATA31C1 (ENSG00000230246), (ENSG00000251545), SPATA31A3 (ENSG00000275969), SPATA31A5 (ENSG00000276581)
Protein
Protein identifiers
Spermatogenesis-associated protein 31A7 — Q8IWB4 (reviewed: Q8IWB4)
Alternative names: Protein FAM75A7
All UniProt accessions (1): Q8IWB4
UniProt curated annotations — full annotation on UniProt →
Function. May play a role in spermatogenesis.
Subcellular location. Membrane.
Similarity. Belongs to the SPATA31 family.
RefSeq proteins (1): NP_056482* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR027970 | SPATA31-like | Domain |
| IPR039509 | SPATA31 | Domain |
Pfam: PF14650, PF15371
UniProt features (26 total): sequence conflict 10, compositionally biased region 7, region of interest 7, chain 1, transmembrane region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8IWB4-F1 | 39.02 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 24 (showing top):
GOZGIT_ESR1_TARGETS_DN, MODULE_511, GOBP_MALE_GAMETE_GENERATION, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, MODULE_163, MIR548D_3P, MIR548H_3P_MIR548Z, MIR548BB_3P, MIR548AC, MIR519A_2_5P_MIR520B_5P, MIR4684_5P, MIR6833_5P, MIR5586_3P
GO Biological Process (2): spermatogenesis (GO:0007283), cell differentiation (GO:0030154)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| cellular developmental process | 1 |
| binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
138 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SPATA31A7 | SPATA32 | Q96LK8 | 855 |
| SPATA31A7 | MT-CO3 | P00414 | 478 |
| SPATA31A7 | TBCCD1 | Q9NVR7 | 398 |
| SPATA31A7 | LGMN | Q99538 | 366 |
| SPATA31A7 | UQCRFS1 | P47985 | 321 |
| SPATA31A7 | GALM | Q96C23 | 320 |
| SPATA31A7 | RESF1 | Q9HCM1 | 313 |
| SPATA31A7 | ATP5MC2 | Q06055 | 311 |
| SPATA31A7 | PRSS33 | Q8NF86 | 310 |
| SPATA31A7 | ZC2HC1B | Q5TFG8 | 273 |
| SPATA31A7 | CNTNAP3 | Q9BZ76 | 272 |
| SPATA31A7 | ATP5MC3 | P48201 | 271 |
| SPATA31A7 | ATP5MC1 | P05496 | 261 |
| SPATA31A7 | APEX2 | Q9UBZ4 | 245 |
| SPATA31A7 | ATP23 | Q9Y6H3 | 223 |
| SPATA31A7 | ATPAF1 | Q5TC12 | 223 |
IntAct
8 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| DEFB103A | SPATA31A7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ODAM | SPATA31A7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ALB | CNOT1 | psi-mi:“MI:0914”(association) | 0.350 |
| SPATA31A7 | DEFB103A | psi-mi:“MI:0915”(physical association) | 0.000 |
| SPATA31A7 | ODAM | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (5): SPATA31A7 (Two-hybrid), SPATA31A7 (Two-hybrid), SPATA31A7 (Two-hybrid), SPATA31A7 (Affinity Capture-MS), SPATA31A7 (Affinity Capture-MS)
ESM2 similar proteins: A0A096LP49, A6NGG8, A6NNH2, B1ASB6, B4DYI2, B6VQA5, C0HKD1, C0HKD2, C0HKD3, D2J0Y4, D6RGX4, E9QAF0, P0C874, P0DKV0, Q149B8, Q3KR64, Q4R736, Q4V8B5, Q5TZJ5, Q5VU36, Q5VVP1, Q5VWK0, Q5VYM1, Q5VYP0, Q63HN1, Q658T7, Q68A65, Q6NS69, Q6NXZ1, Q6PAC4, Q6ZQQ2, Q6ZU69, Q6ZUB0, Q6ZUB1, Q7TSA6, Q80X53, Q86Y26, Q8BHP2, Q8BHW6, Q8C0D9
Diamond homologs: B4DYI2, B6VQA5, E9QAF0, P0C874, P0DKV0, Q5TZJ5, Q5VU36, Q5VVP1, Q5VYP0, Q6ZQQ2, Q6ZUB0, Q6ZUB1, Q8IWB4, A6NFR6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
150 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 135 |
| Likely benign | 15 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
531 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:61192076:C:CC | acceptor_gain | 0.9900 |
| 9:61190252:C:A | donor_loss | 0.9800 |
| 9:61190252:CCTTT:C | donor_gain | 0.9800 |
| 9:61190253:A:AT | donor_loss | 0.9800 |
| 9:61190254:TAC:T | donor_loss | 0.9800 |
| 9:61190255:TTA:T | donor_loss | 0.9800 |
| 9:61190256:CTTAC:C | donor_loss | 0.9800 |
| 9:61190257:CCTTA:C | donor_loss | 0.9800 |
| 9:61192079:CAGC:C | acceptor_gain | 0.9800 |
| 9:61192080:CCAG:C | acceptor_gain | 0.9800 |
| 9:61192079:CAG:C | acceptor_gain | 0.9700 |
| 9:61192138:CCT:C | donor_gain | 0.9600 |
| 9:61190252:C:CC | donor_gain | 0.9500 |
| 9:61190253:A:AC | donor_gain | 0.9500 |
| 9:61192138:CCTC:C | donor_loss | 0.9500 |
| 9:61192139:ACCT:A | donor_loss | 0.9500 |
| 9:61192140:CA:C | donor_loss | 0.9500 |
| 9:61192141:TCACC:T | donor_loss | 0.9500 |
| 9:61192142:CTCA:C | donor_loss | 0.9500 |
| 9:61192143:CCTCA:C | donor_loss | 0.9500 |
| 9:61190389:C:CA | donor_gain | 0.9400 |
| 9:61192928:G:T | acceptor_gain | 0.9400 |
| 9:61192076:C:CG | acceptor_loss | 0.9300 |
| 9:61192076:C:A | acceptor_gain | 0.9200 |
| 9:61192077:GCT:G | acceptor_gain | 0.9200 |
| 9:61192078:AG:A | acceptor_gain | 0.9200 |
| 9:61192625:G:C | donor_gain | 0.9200 |
| 9:61192078:A:T | acceptor_gain | 0.9100 |
| 9:61192078:AGCTG:A | acceptor_gain | 0.9100 |
| 9:61192392:C:CC | acceptor_gain | 0.9100 |
AlphaMissense
8804 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:61193332:T:C | F416L | 0.964 |
| 9:61193334:C:A | F416L | 0.964 |
| 9:61193334:C:G | F416L | 0.964 |
| 9:61193335:T:A | W417R | 0.915 |
| 9:61193335:T:C | W417R | 0.915 |
| 9:61194523:T:A | W813R | 0.906 |
| 9:61194523:T:C | W813R | 0.906 |
| 9:61193425:T:C | F447L | 0.902 |
| 9:61193427:C:A | F447L | 0.902 |
| 9:61193427:C:G | F447L | 0.902 |
| 9:61193338:G:C | G418R | 0.884 |
| 9:61194457:T:C | F791L | 0.884 |
| 9:61194459:C:A | F791L | 0.884 |
| 9:61194459:C:G | F791L | 0.884 |
| 9:61194525:G:C | W813C | 0.870 |
| 9:61194525:G:T | W813C | 0.870 |
| 9:61193337:G:C | W417C | 0.853 |
| 9:61193337:G:T | W417C | 0.853 |
| 9:61193791:T:C | F569L | 0.836 |
| 9:61193793:T:A | F569L | 0.836 |
| 9:61193793:T:G | F569L | 0.836 |
| 9:61193356:A:C | S424R | 0.816 |
| 9:61193358:C:A | S424R | 0.816 |
| 9:61193358:C:G | S424R | 0.816 |
| 9:61195123:T:C | F1013L | 0.795 |
| 9:61195125:T:A | F1013L | 0.795 |
| 9:61195125:T:G | F1013L | 0.795 |
| 9:61193333:T:C | F416S | 0.788 |
| 9:61193860:A:C | S592R | 0.767 |
| 9:61193862:T:A | S592R | 0.767 |
dbSNP variants (sampled 300 via entrez): RS1001101089 (9:61194070 C>T), RS1002311561 (9:61191144 T>C), RS1002580399 (9:61192178 G>A,T), RS1008986881 (9:61189505 A>C), RS1009124066 (9:61188556 A>G), RS1009424455 (9:61192252 G>A), RS1009666147 (9:61193821 G>C,T), RS1019075123 (9:61189422 A>C), RS1019182685 (9:61188544 G>C), RS1025089941 (9:61193801 C>G), RS1026523057 (9:61190678 G>A), RS1026553865 (9:61191986 C>T), RS1028062223 (9:61188432 T>C), RS1032185845 (9:61194003 A>G), RS1034338540 (9:61193526 A>C)
Disease associations
OMIM: gene MIM:616584 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.